These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2357245)

  • 1. Pharmacokinetics of bamifylline during chronic therapy.
    Segre G; Cerretani D; Moltoni L; Urso R; Fusillo M
    Arzneimittelforschung; 1990 Apr; 40(4):450-2. PubMed ID: 2357245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic and pharmacokinetic studies on Bamifylline. A review.
    Dodion L; Aylward M
    Rev Inst Hyg Mines (Hasselt); 1978; 33(4):204-10. PubMed ID: 552145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of pulmonary tropism of bamifylline and its main active metabolite.
    Schiantarelli P; Acerbi D; Botta GC; Bonati L; Capelli P; Rondelli I
    Arzneimittelforschung; 1989 Feb; 39(2):215-9. PubMed ID: 2730690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of a new sustained-release formulation of theophylline sodium glycerinate in healthy subjects with a new asymmetric dosage regimen.
    Wang P; Qi M; Zhong D; Fang L
    Biomed Chromatogr; 2003 Jan; 17(1):58-61. PubMed ID: 12583008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerability and in vivo performance of a novel freon-free metered dose inhaler for a fixed combinational product of reproterol and disodium cromoglycate.
    Hermann R; Ruus P; Schneider E; de Mey C
    Arzneimittelforschung; 1998 Jun; 48(6):663-7. PubMed ID: 9689424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ventilatory effect and side effects of oral bamifylline].
    Minette A
    Rev Inst Hyg Mines (Hasselt); 1978; 33(4):211-21. PubMed ID: 552146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bamifylline in the treatment of chronic bronchial obstruction: a controlled clinico-functional study versus an anhydrous theophylline administered once a day].
    Caputi M; Cautiero V; Aliberti M; Monici Preti PA; Oliani C
    Arch Monaldi Mal Torace; 1988; 43(5):409-21. PubMed ID: 3079283
    [No Abstract]   [Full Text] [Related]  

  • 9. Kinetics of theophylline in apnea of prematurity in small for gestational age babies.
    Chaudhuri M; Garg SK; Narang A; Bhakoo ON
    Indian Pediatr; 1996 Mar; 33(3):181-7. PubMed ID: 8772836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronopharmacokinetics of theophylline administered as a controlled-release tablet.
    Thielemann AM; Manquez N; Pinilla E; Gai MN; Romero P; Arancibia A; Chavez H
    Int J Clin Pharmacol Ther; 1996 Mar; 34(3):130-3. PubMed ID: 8705090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of morning or evening administration on absorption of theophylline.
    Su YM; Cheng TP; Yeh TW; Wen CY; Wang DI
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):113-8. PubMed ID: 10677921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of sustained-release in theophylline (Slobid, Theolong, Theodur) by pharmacokinetics].
    Kotake T; Mihara M; Shibakawa M; Asamoto
    Arerugi; 1997 Apr; 46(4):370-5. PubMed ID: 9154697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of Unilair in general practice conditions. Treatment of chronic obstructive airway diseases with theophylline].
    Gregori P; Hader S; Samiri H; Wiemann M; Yousif MJ; Kiebart M
    Fortschr Med; 1997 Jan; 115(1-2):54-5. PubMed ID: 9102383
    [No Abstract]   [Full Text] [Related]  

  • 14. Apparent decrease in population clearance of theophylline: implications for dosage.
    Asmus MJ; Weinberger MM; Milavetz G; Marshik P; Teresi ME; Hendeles L
    Clin Pharmacol Ther; 1997 Nov; 62(5):483-9. PubMed ID: 9390104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative effects of bamifylline and theophylline on allergenic bronchospasm induced by the provocative inhalation test : double-blind cross-over study].
    Kofman J; Grosclaude M; Ouechni MM; Perrin-Fayolle M
    Poumon Coeur; 1982; 38(3):197-202. PubMed ID: 6752929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
    Ahn HC; Lee YC
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New pharmacological data on the bronchospasmolytic activity of bamifylline.
    Berti F; Magni F; Rossoni G; Schiantarelli P; Bongrani S; Pasargiklian R
    Arzneimittelforschung; 1988 Jan; 38(1):40-4. PubMed ID: 3365275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of the theophylline pharmacokinetics of sustained-release theophylline (Theodur) dry syrup in children].
    Okuma M; Iikura Y
    Arerugi; 1999 Jun; 48(6):589-96. PubMed ID: 10423899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets.
    Gai MN; Isla A; Andonaegui MT; Thielemann AM; Seitz C
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):565-71. PubMed ID: 9455715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.